Literature DB >> 28671133

Chinese Medicine: A Hope for Neurodegenerative Diseases?

Betty Yuen Kwan Law1,2, An Guo Wu1, Min Jun Wang1,2, Yi Zhun Zhu1,2.   

Abstract

With the increase in the proportion of aged population due to the rapid increase of life expectancy, the worldwide prevalence rate of multiple neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, and Huntington's disease has been increased dramatically. The demographic trend toward an older population has drawn the attention to new drug discovery and treatment on age-related diseases. Although a panel of drugs and/or therapies are currently available for treating the neurodegenerative diseases, side effects or insufficient drug efficacy have been reported. With the long history in prescription of Chinese medicine or natural compounds for modulating aged-related diseases, emerging evidence was reported to support the pharmacological role of Chinese medicine in ameliorating the symptoms, or interfering with the pathogenesis of several neurodegenerative diseases. This review brings evidence about today's trends and development of a list of potential neuroprotective herbal compounds from both the traditional and modern pharmacological point of view. With future projections, the potential hope and implication of using Chinese medicine as an alternative source for novel drug discovery for neurodegenerative diseases is proposed.

Entities:  

Keywords:  Aging; Alzheimer’s disease; Chinese medicine; Parkinson’s disease; amyloid-β; autophagy; disease proteins; leonurine; neurodegenerative diseases; α-synuclein

Mesh:

Year:  2017        PMID: 28671133     DOI: 10.3233/JAD-170374

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  6 in total

1.  High-frequency (50 Hz) electroacupuncture ameliorates cognitive impairment in rats with amyloid beta 1-42-induced Alzheimer's disease.

Authors:  Chao-Chao Yu; Ying Wang; Feng Shen; Li-Hong Kong; Ya-Wen Wang; Hua Zhou; Lei Tang
Journal:  Neural Regen Res       Date:  2018-10       Impact factor: 5.135

2.  Systems Pharmacology Approach to Investigate the Mechanism of Kai-Xin-San in Alzheimer's Disease.

Authors:  Yunxia Luo; Dongli Li; Yanfang Liao; Chuipu Cai; Qihui Wu; Hanzhong Ke; Xinning Liu; Huilin Li; Honghai Hong; Yumin Xu; Qi Wang; Jiansong Fang; Shuhuan Fang
Journal:  Front Pharmacol       Date:  2020-04-03       Impact factor: 5.810

Review 3.  Therapeutic roles of natural remedies in combating hereditary ataxia: A systematic review.

Authors:  Michael Weng Lok Phang; Sze Yuen Lew; Ivy Chung; William Kiong-Seng Lim; Lee Wei Lim; Kah Hui Wong
Journal:  Chin Med       Date:  2021-01-28       Impact factor: 5.455

4.  Astragaloside IV Protects 6-Hydroxydopamine-Induced SH-SY5Y Cell Model of Parkinson's Disease via Activating the JAK2/STAT3 Pathway.

Authors:  ZhengHu Xu; Dongfeng Yang; Xiaojing Huang; Huai Huang
Journal:  Front Neurosci       Date:  2021-03-23       Impact factor: 4.677

5.  Discovery and characterization of naturally occurring potent inhibitors of catechol-O-methyltransferase from herbal medicines.

Authors:  Dong-Fang Zhao; Yu-Fan Fan; Fang-Yuan Wang; Fan-Bin Hou; Frank J Gonzalez; Shi-Yang Li; Ping Wang; Yang-Liu Xia; Guang-Bo Ge; Ling Yang
Journal:  RSC Adv       Date:  2021-03-11       Impact factor: 3.361

6.  The Combination of Salidroside and Hedysari Radix Polysaccharide Inhibits Mitochondrial Damage and Apoptosis via the PKC/ERK Pathway.

Authors:  Sixia Yang; Linshuang Wang; Zeping Xie; Yi Zeng; Qiaowu Xiong; Tingting Pei; Dongfeng Wei; Weidong Cheng
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-25       Impact factor: 2.650

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.